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High-affinity binding sites for VIP in renal cortical membranes: Possi-
ble role of VIP in renal transport. We studied binding and degradation of 
vasoactive intestinal peptide (VIP) by highly purified brush border and 
basolateral membranes from rabbit kidney cortex. Brush border and 
basolateral membranes were capable of 73 and 49% degradation of VIP 
after 20 minutes, and the degradation was totally prevented by bacitra-
cin. There was 66 and 87% specific binding of 12sI_VIP to brush border 
and basolateral membranes, respectively. 12SI-VIP binding to renal 
membrane was displaced in a dose dependent fashion by unlabeled VIP 
with half maximal displacement at 2 x 10-7 M. Other related peptides 
failed to displace VIP. Scatchard analysis showed one single class of 
receptors for VIP in both membranes with similar Kd (0.5 :x: 10-7 M) but 
higher number of binding sites (Bmax) in the basolateral membranes than 
in the brush border membranes (22.0 vs. 4.4 pmollmg protein), respec-
tively. Forty-eight percent of VIP binding to brush border membranes 
could be explained by cross contamination of these membranes with 
basolateral membranes. We examined the effect of VIP on Na-H 
antiporter, Na-dependent glucose uptake and Na-dependent phosphate 
uptake by isolated proximal tubule suspension. In acid loaded proximal 
tubules VIP (10-6 M) inhibited total arid amiloride-sensitive 22Na uptake 
by 35 and 75%, respectively, as compared to control. On the other hand 
VIP failed to inhibit Na-dependent methyl a- 14C-glucopyranoside and 
Na-dependent 32phosphate uptake. VIP failed to stimulate cyclic AMP 
generation by proximal tubule suspension while PTH showed· the 
expected stimulation. Our results demonstrate the presence of specific 
binding for VIP in highly purified cortical membranes and suggest an 
effect of VIP to inhibit the Na-H antiporter by a mechanism indepen-
dent of cyclic AMP. 
The role and mode of action of vasoactive intestinal peptide 
(VIP) in renal function is largely unknown. This "gastrointes-
tinal peptide" neurotransmitter is widely distributed and has 
diverse effects in a variety of tissues [1--4]. Immunoreactive YIP 
has been localized to renal neurons, mainly in the cortex, 
associated with the renal artery and arterioles [5, 6]. Because of 
the known potent vasodilator properties of VIP in other tissues 
and the proximity of immunoreactive staining to arteries and 
arterioles, it has been hypothesized that VIP may have a renal 
vasodilator role. Stimulation of water and electrolyte secretion 
in the intestine by VIP has also been well characterized, and a 
role for VIP regulation of renal tubular transport has been 
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suggested [7-13]. Moreover, there is strong evidence that VIP 
has a direct effect on electrolyte transport by epithelia which 
have strong analogy to segments of the nephron [14-17]. 
Calam et al [18] demonstrated that intravenous infusions of 
YIP into healthy men resulted in a reduction in renal vascular 
resistance in the face of reduced systemic blood pressure. 
Rather than stimulating excretion, a net increase in fractional 
reabsorption of sodium, potassium and chloride was observed, 
which Was attributed to a hemodynamic effect of VIP. In 
contrast, Dimaline, Peart and Unwin [19] demonstrated that 
intravenous VIP infusion into conscious rabbits resulted in 
significant enhancement of sodium, potassium and chloride 
excretion despite a fall in renal blood flow and glomerular 
filtration rate. When VIP was infused directly into the renal 
artery of anesthetized dogs, renal vasodilation was demon-
strated [201. In the isolated perfused kidney, however, VIP 
infusion had no effect on vascular resistance but produced 
significant increases in urine volume and the fractional excre-
tion of electrolytes, strongly suggesting an action of VIP 
directly on tubular transport [21]. 
Thus, the results from in vivo studies of the effect of VIP in 
renal function has been contradictory, some studies supporting 
a primary hemodynamic action and other studies a primary 
effect on tubular transport [18, 19]. A clear understanding of the 
mechanism of VIP regulation of kidney function is not possible 
in these in vivo studies because a multitude of uncontrollable 
systemic factors can alter the renal response to intravenous 
VIP. In the present study, we studied binding and degradation 
of VIP by highly purified luminal and basolateral membranes 
and evaluated the effect of VIP on tUbular transport by isolated 
proximal tubule suspension of the rabbit kidney. 
Methods 
Experiments were performed on New Zealand white rabbits 
(weighing 3 to 61b) which were fed a normal diet. Preparation of 
brush border and basolateral membranes of renal cortex were 
performed utilizing the technique of Kinsella et al [22] as 
previously described by our laboratory [23, 24]. Brush border 
membranes were enriched tenfold in alkaline phosphatase and 
T-glutamyl transferase and basolateral membranes were en-
riched 13-fold in Na-K-ATPase activity. Cross contamination of 
basolateral (BL) with brush border (BB) membranes vesicles 
and vice versa were calculated using the absolute activities of 
alkaline phosphatase and Na-K-ATPase activities in the prep-
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arations according to the equation described by Cheng and 
Hammerman [25]. The equation for cross contamination of 
BBMV with BLMV was as follows: 
BBMV alkaline phosphatase activity x 100% 
. 
100% - % contamination of BLMV in BBMV 
BBMV alkaline phosphatase activity x 100% 
% contamination of BLMV in BBMV 
A similar formula was used to calculate cross contamination of 
BLMV with BBMV. 
Binding and degradation of 125I-VIP by renal cortical 
membranes 
For binding and degradation experiments we utilized 1251_ VIP 
(20 pM) which was added to a suspension ofbasolateral or brush 
border membranes (100 to 300 /Lg protein) in specially coated 
tubes contained a buffer of the following composition: mannitol 
100 mM, glycylgcine 25 mM, bovine serum albumin 1%, pH 8 at 
room temperature [26]. Adsorption of 1251_ VIP by the tubes was 
prevented by precoating the tubes with polyethylenimine and 
an organosilane. For the degradation experiments, membranes 
were incubated in the absence and in the presence of 1 % 
bacitracin or other protease inhibitors for 10 to 30 minutes [26, 
27]. The reaction was terminated by adding 250 /LI of 20% TCA. 
Separation of the membranes from the incubation medium was 
accomplished by centrifugation at 4°C at 8000 g for 10 minutes. 
The radioactivity in pellet and in the supernatant was deter-
mined and the amount remaining in the supernatant was con-
sidered degraded 1251_VIP. Once we determined that bacitracin 
was an effective inhibitor of the degradation of VIP, all subse-
quent experiments were performed in the presence of 1 % 
bacitracin [27]. For binding experiments the membranes were 
incubated in the above described buffer in the presence of 20 pM 
1251_ VIP for 20 minutes at 22°C and in the absence and presence 
of varying amounts of excess unlabeled VIP. The reaction was 
terminated by addition of ice-cold buffer containing 5% bacitra-
cin followed by rapid filtration through specially coated filters. 
The filters were rinsed twice, removed, dried overnight and 
counted in a gamma counter. Nonspecific binding was deter-
mined by the amount of 1251_VIP bound to the membrane in 
presence of excess unlabeled VIP. 
Isolation of proximal tubule suspension 
For experiments examining the effect of VIP on tubular 
transport we utilized a proximal tubule suspension isolated 
according to the method of Chung et al [28]. In brief, New 
Zealand white rabbits (3 to 6 lb) were anesthetized with 
nembutal (50 mg/kg). The aorta was cannulated and the kidneys 
perfused in situ with sterile serum-free medium (DMEM/FI2) 
containing particulate iron oxide. The kidneys were dissected 
free from the abdominal cavity, the capsule was removed, and 
the cortex was then dissected free from medullary tissue and 
homogenized in a Dounce homogenizer. The homogenate was 
serially filtered through two nylon mesh screens having pore 
sizes of 250 microns and 44 microns. The material which 
traversed the former screen but was retained in the latter screen 
contained both tubules and glomeruli-the latter being removed 
with a sterile magnet. The resultant tubule suspension was 
briefly exposed to collagenase, washed with sterile medium and 
used for transport by suspending the tubule suspension in the 
appropriate buffer. Electron microscopy studies of the isolated 
tubules showed that more than 98% were proximal tubules . 
22 Na uptake by proximal tubule suspension in presence of a 
pH gradient 
22Na uptake by isolated proximal tubules was performed as 
follows: the tubule suspension was washed and pre-equilibrated 
for 20 minutes in a buffer containing 120 mM TMA-CI, 5 mM 
KCI, 1 mM CaCI2, 1 mM MgCI2, 18 mM MES, 14 mM Hepes, 14 
mM Tris-Base, pH 6.4. The tubules were resuspended in this 
incubation buffer containing 1 % bacitracin and with 10-5 M VIP 
or equal volume of the vehicle (acetic acid), and incubated for 
30 minutes at 37°C. Transport buffer contained 119 mM TMA-
CI, 25 mM NaCI, 5 mM KCI, 1 mM CaCI2, 1 mM MgCI2, 28 mM 
Hepes, 18 mM Tris-Base, pH 7.4. Ouabain at 0.1 mM was 
included to inhibit Na-K-ATPase [29]. Using a ratio of 80 /LI 
transport buffer to 106 cells in 20 /LI, the final extracellular pH 
was 7.4 with intracellular pH of approximately 6.4. (In other 
experiments utilizing the fluorescent probe BCECF in isolated 
proximal tubular suspension, we showed that intracellular pH 
approaches the extracellular pH with 20 minutes of incubation.) 
This low intracellular pH provides an outward H+ gradient 
which favors Na uptake. In addition, 1.0 /LCi 22Na was added to 
the transport buffer. Amiloride at 1 mM was used to inhibit the 
Na uptake. The time course was one minute. This time was 
chosen because preliminary experiments indicated that the rate 
of 22Na uptake was linear up to two minutes. The reaction was 
stopped by addition of 1 ml of ice-cold 149 mM LiCI, 0.5 mM 
Tris base, 0.5 mM Hepes, pH 7.5 and filtered rapidly through a 
Millipore filter with an additional 15 ml of stop-solution. The 
filters with trapped cells were assayed for radioactivity in a 
scintillation counter. The amiloride inhibitable Na uptake was 
expressed as Na-H antiporter activity in pmoUmg protein. 
Na-dependent 32phosphate uptake 
Na-dependent 32phosphate uptake by isolated proximal tu-
bule suspension was measured in the presence and in the 
absence of sodium as described by Paujeol and Vandewalle 
[30]. The tubule suspension was incubated in a buffer containing 
280 mM mannitol, 10 mM Hepes, 2 mM glutamine, 1 mM 
pyruvate, 0.1 mM MgS04 , 0.25 mM CaCI2, pH 7.35. The tubules 
were resuspended in this incubation buffer containing 1 % 
bacitracin and with 10-5 M VIP or equal volume of the vehicle 
(acetic acid), and incubated for 30 minutes at 37°C. The 
transport buffer contained 140 mM NaCI or KCI, 10 mM Hepes, 
4 mM potassium phosphate with 10 /LCi, 32p at 37°C. To initiate 
the uptake, 10 /LI of tubule suspension was added to the 
transport buffer for 1 to 60 minutes, and after this time interval 
the reaction was stopped by adding one ml of ice-cold solution 
containing 149 mM LiCI, 0.5 mM Tris-Base and 0.5 mM Hepes. 
The tubule suspension was centrifuged, washed and the pellet 
was dissolved in NaOH, and radioactivity was determined. 
32Phosphate uptake experiments were performed in the pres-
ence and in the absence of 10-5 M VIP in the presence and in the 
absence of NaCI (NaCI was replaced by KCl). 
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Na-dependent methyl a-D 14C-glucopyranoside by isolated 
proximal tubule suspension 
Tubule suspension was washed twice with a preincubation 
buffer containing 250 mM mannitol, 1 mM CaCI2, 1 mM MgCI2, 
14 mM Hepes and 10 mM Tris-Base to remove any remaining 
DMEM-FI2 solution in the tubules [28]. The tubules were 
resuspended in this incubation buffer containing 1 % bacitracin 
and with 10-5 M VIP or equal volume of the vehicle (acetic acid) 
and incubated for 30 minutes at 37°C. After preincubation of the 
tubules, they were transferred to precoated polystyrene tubes 
and incubated in 125 mM NaCI or KCI, 1 mM CaCI2, 1 mM 
MgCI2, 28 mM Hepes, 18 mM Tris-Base, 1 mM methyl (a_D_ 14C_ 
glucopyranoside (a MGP) and 50 ILM 14C-a-MGP for 1 to 60 
minutes at 37°C. The reaction was then stopped by adding 4 ml 
ice-cold solution containing 149 mM LiCI, 0.5 mM Tris-Base, 0.5 
mM Hepes pH 7.50 and rinsed twice on Millipore GFA filters. 
The filters containing the tubules were then counted in a beta 
scintillation counter. 
Cyclic AMP measurement 
Cyclic AMP was measured in isolated proximal tubule sus-
pension before (basal cyclic AMP generation) and after stimu-
lation with PTH, forskolin, vasopressin or VIP. Isolated tubule 
suspension was incubated for various times in the presence and 
absence of these known simulators of adenylate cyclase and 
VIP with or without the addition of the phosphodiesterase 
inhibitor, l-isobutyl-3-methylxanthine (IBMX), and in the pres-
ence of inhibitors of VIP degradation [31, 32]. The reaction was 
stopped by addition of ice-cold buffer (DMEM/F12) and rapid 
centrifugation of suspended cells in a Beckman microcentri-
fuge. Cells were resuspended in buffer (potassium phosphate 5 
mM, KCI 150 mM, EDTA 2 mM) containing IBMX (0.5 mM), 
sonicated 10 seconds, boiled for six minutes and then centri-
fuged. Cyclic AMP was measured in the supernatant by a 
radioimmunoassay using antibody obtained from ICN Immuno-
logicals, Inc. 
Results are presented as mean ± SEM. The t-test for paired or 
unpaired data was used wherever appropriate. Linear regres-
sion was calculated by the least square method. 
Results 
Degradation of 125I-VIP by brush-border basolateral 125I_VIP 
renal membrane 
Figure 1 shows the percent degradation of 1251_ VIP by highly 
purified brush border and basolateral membranes. It can be 
seen that brush border membranes rapidly degraded 1251_VIP 
with a rate of 60% degradation at 10 minutes, and this rate of 
degradation remained stable thereafter. In contrast, degrada-
tion by basolateral membranes was 20% at 10 minutes and 
increased to 55% at 30 minutes. Figure 2 summarizes the 
degradation of 1251_ VIP at 20 minutes by brush border and 
basolateral membrane in the absence (open bars) and in the 
presence of 1% bacitracin (shaded bars). It is clear that baci-
tracin totally prevented the degradation of VIP by both brush 
border and basolateral membranes. We also tested the ability of 
other protease inhibitors to prevent the degradation of VIP by 
basolateral membranes [26, 27]. Leupeptin (2 ILglml), N-ethyl-
maleimide (1 mM), NH4CI (100 mM), soybean trypsin inhibitor 
(50 ILglml), and phenylmethylsulfonyl fluoride (20 ILg/ml) failed 
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Fig. 1. Degradation of 125I-VIP by luminal (e) and basolateral mem-
branes (0). N = 3 to 4. 
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Fig. 2. VIP degradation by luminal (left panel) and basolateral mem-
branes (right panel) in the absence (open bars) and in the presence of 
1% bacitracin (hatched bars). N = 8. 
to prevent the degradation of 1251_VIP as compared to control. 
Therefore, in all subsequent experiments we utilized 1% baci-
tracin to prevent degradation of VIP. 
Binding of I25I-VIP by basolateral and brush border 
membranes 
Figure 3 shows the displacement of 1251_VIP bound to baso-
lateral membranes by excess amounts of unlabeled VIP. It can 
be seen that unlabeled VIP displaced 1251_ VIP bound to baso-
lateral membranes in a dose dependent fashion with 50% 
displacement at 2 x 10-7 M and maximal displacement at 10-6 
M. Not shown is the fact that other hormones PTH, secretin and 
somatostatin failed or displaced minimally 1251_ VIP bound by 
basolateral membranes. 
The data of VIP binding to basolateral membranes was 
analyzed by the saturation binding curve program defined by 
the equation y = A *X/(B + X), where X is the concentration of 
unlabeled VIP, y is the amount of specifically bound VIP, B is 
the dissociation constant (Kd) and A is the Bmax [33]. This 
curve fitted well the data as evidenced by a correlation coeffi-
cient of 0.84 and a Kd of2.2 x 10-7 M. Thus, the Kd determined 
from the displacement curve is close to Kd determined satura-
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tion binding curve program. These data were also analyzed by 
Scatchard plot which is shown in Figure 4. These data are well 
fitted by linear regression with correlation of coefficient of 0.89, 
suggesting one class of receptor for VIP in the basolateral 
membranes with maximal number of binding of 22 pmollmg 
protein and Kd of 0.5 x 10-7 M. Thus, the Kd determined from 
the Scatchard analysis is close to the apparent Kd determined 
from the saturation curve. Figure 5 shows the Scatchard plot of 
VIP binding to brush border membranes. Again, one single 
class of receptor for VIP is disclosed with Bmax of 4.4 pmollmg 
protein and Kd of 0.4 x 10-7 M. There was 8% cross contam-
ination of the luminal membranes with basolateral membrane 
(Methods). This contamination of brush border membrane with 
basolateral membranes can account for 2.1 pmollmg protein 
(48%) of VIP binding to brush border membranes. 
Effect of VIP on tubule transport 
Preliminary experiments indicated that 22Na uptake in-
creased with time and reached a peak level at one minute; for 
this reason all subsequent experiments were performed at one 
minute . Figure 6 shows 22Na uptake at one minute in presence 
pmol Bound/mg protein 
Fig. 5. Scatchard plot oj125I_ VIP binding to luminal membranes . N = 
4; r = 0.86. 
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Fig. 6. 22Na uptake at 1 min by acid-loaded proximal tubule suspen-
sion under control condition (left panel) and in presence of 10-6 M VIP 
(right panel). Asterisks refer to comparison to control *P < 0.005, **P 
< 0.025. N = 8. Symbols are: (~) total ; (l1li) + amiloride; (_) amiloride 
sensitive. 
of 20 mM Na by isolated proximal tubules loaded with acid (pH 
6.4) and suspended in buffer of pH 7.4 to generate a pH 
gradient. It is clear that there is 22Na uptake which is inhibited 
approximately 30% by amiloride (10- 3 M), indicating the pres-
ence of Na-H antiporter in the isolated proximal tubule suspen-
sion. Addition of 10-6 M VIP resulted in a significant 35% 
inhibition of total 22Na uptake as compared to control tubules 
(P < 0.005). VIP inhibited the amiloride-sensitive 22Na uptake 
by 75% at 10-6 M (P < 0.025). The amiloride-insensitive 22Na 
uptake was not inhibited by VIP. 
Figure 7 shows evidence of Na-dependent glucose transport 
in the isolated tubule suspension as evidenced by the fact that 
a-MGP uptake was higher in the presence ofNa than K. a-MGP 
uptake peaked at one minute and reached an equilibrium at 60 
minutes. The effect of VIP (10-5 M) in a-MGP uptake in the 
presence of Na or K was examined at 15 seconds, 1 minute, 5 
minutes, and 60 minutes. At all time intervals, VIP failed to 
alter Na dependent a-MGP uptake (control 1.82 ± 0.25 vs. 1.60 
± 0.18 nmol/mg protein at 1 min, N = 13). 
Table 1 shows Na-dependent 32phosphate uptake in absence 
and in the presence of 10- 5 M VIP at one minute. At times 15 
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seconds, 30 seconds, 1 minute and 60 minutes there was 
stimulation of 32phosphate uptake in presence of Na+ as 
compared to K+, indicating the presence of Na-dependent 
phosphate uptake. At this and all other time intervals, VIP 
failed to alter Na-dependent or independent phosphate uptake. 
Effect of VIP on cyclic AMP generation by isolated proximal 
tubule 
Figure 8 shows cyclic AMP before (basal) and after addition 
of different hormones. As expected PfH and forskolin stimu-
lated, while AVP did not alter cyclic AMP levels. VIP (10- 7 M), 
not shown up 10-5 M, failed to stimulate cyclic AMP produc-
tion. In presence of IBMX, VIP also failed to stimulate cyclic 
AMP levels. 
Discussion 
Our study provides evidence for presence of specific recep-
tors for VIP in highly-purified renal brush border and basolat-
eral membranes. These membranes are capable of degrading 
VIP and studies on proximal tubule suspension strongly suggest 
that VIP inhibits the Na-H antiporter. Previous studies in man, 
in animals and in the isolated perfused kidney have suggested a 
role for VIP in renal function, but from these studies it is 
unclear whether the effect of VIP on renal function is due to the 
direct tubular effect or to the hemodynamic effects elicited by 
VIP [18-21]. Previous studies have attempted to determine 
binding and degradation of VIP in plasma membranes of the 
renal cortex and in kidney slices [34, 35]. Griffiths and Simmons 
[34] demonstrated the presence of specific binding and degra-
dation of VIP in plasma membranes from the cortex and renal 
medulla. They found that cortical membranes were capable of 
30% degradation of VIP with maximal binding sites of 0.219 
nmoUmg protein and half maximal binding of 3.3 P.M. More 
recently Griffiths and Simmons [35] reported that the binding of 
VIP to microsomes of the feline renal cortex had a Kd of 8.4 p.M 
for the high affinity receptor, which is very close to the results 
found in the present study. Magistretti et al [36] found half 
maximal binding of 10 P.M utilizing autoradiography of kidney 
slices. In both of these studies it is impossible to determine the 
contribution of the brush border versus the basolateral mem-
branes in binding and degradation of VIP. In the present study 
we characterized binding and degradation of VIP by highly-
purified brush border and basolateral renal cortical membranes 
and thus could determine the relative contribution of these 
membranes to VIP binding and degradation. Our studies clearly 
demonstrate a much lower Kd and higher Bmax as compared to 
previous studies. This difference is undoubtedly accounted for 
by the use of highly-purified renal cortical membranes. We 
found that degradation of VIP was higher in the brush border 
membranes than in basolateral membranes, while in the latter 
the maximal number of binding sites was six times greater than 
in the brush border membranes. As discussed in the results, 
48% of VIP binding to brush border membranes can be ac-
counted for by cross contamination of these membranes with 
basolateral membranes. This pattern of binding and degradation 
are in agreement with studies of insulin degradation and binding 
in that the brush border membranes were capable of more 
degradation while having lower number of maximal binding 
sites for this hormone than the basolateral membranes [26]. As 
compared to studies performed in purified intestinal membranes 
[1] our studies show a similar Kd and number of maximal 
binding sites. 
Having demonstrated the presence of specific binding site for 
VIP in renal cortical membranes, we attempted to uncover an 
effect of VIP on transport by studying the effect of this hormone 
on isolated proximal tubular suspension. Proximal tubule sus-
pension contains a Na-H antiporter, Na-glucose cotransporter 
and Na-phosphate cotransporter; these systems have been well 
characterized in vitro [28-30]. In the present study, the rate of 
22Na uptake, (in presence of 20 mM Na), in acid-loaded proxi-
mal tubules was comparable to that recently reported for rat 
proximal tubules but lower than that measured in rabbit prox-
imal tubules [29, 37]. In addition, amiloride inhibited 22Na 
uptake by 30%, a value close to the 40% inhibition observed 
with ethylisopropylamiloride, a more potent inhibitor of the 
Na-H antiporter [37]. VIP caused a significant inhibition of 22Na 
uptake in acid-loaded proximal tubules and affected only the 
amiloride sensitive component of the 22Na uptake. At a lower 
concentration of Na (1 mM) VIP also inhibited the amiloride 
sensitive component of the Na-H antiporter (data not shown). 
Since VIP has been reported to have a weak inhibitory effect 
on Na-dependent phosphate transport in the opossum kidney 
cells [38], we examined the effect of VIP on Na-dependent 
phosphate transport in proximal tubules. As reported by other 
investigators [30], we found that in the presence of Na as 
compared to K, phosphate uptake was higher indicating the 
presence of Na-phosphate cotransporter. VIP, however, failed 
to inhibit Na-dependent phosphate transport. Likewise, VIP 
also failed to inhibit Na-dependent glucose transport. These 
results suggest that the effect of VIP is relatively specific for the 
Na-H antiporter in the proximal tubule. The results of the 
present study suggest that VIP may inhibit acidification not only 
by stimulating HC03 secretion [17] but also by inhibiting the 
Na-H antiporter. 
Cyclic AMP is thought to be the mediator of VIP in many 
tissues [39--41]. Because cyclic AMP is well known to inhibit 
the Na-H antiporter and phosphate transport we measured the 
effect of VIP on cyclic AMP generation by proximal tubule 
suspension [42]. VIP caused minimal or no increase in cyclic 
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Table 1. Na-dependent 32phosphate uptake (n:20; nmol/mg 
protein/60 sec) 
Sodium 
Potassium 
Control 
5.8 ± 0.98 
P < 0.05 
1.36 ± 0.22 
P 
NS 
NS 
VIP (l0-5 M) 
5.70 ± 1.03 
P < 0.001 
1.48 ± 0.26 
AMP generation while PTH and forskolin caused the expected 
increase in cyClic AMP. These findings indicate that preparation 
was adequate to disClose an effect of VIP on cyClic AMP 
generation. Griffiths and Simmons [41] initially reported that 
VIP increased adenylate cyClase activity by rabbit renal baso-
lateral membranes 1.6-fold. However, in a subsequent study, 
these investigators measured the effect of VIP on adenylate 
cyClase activity in isolated tubule segments of the rabbit kidney 
[42]. They found that VIP stimulated adenylate cyClase activity 
in the distal convoluted tubule and in the medullary collecting 
duct, but failed to stimulate the activity of this enzyme in the 
proximal tubule. Thus, our resuits are in agreement with the 
latest results of Griffiths and Simmons et al [35, 43]. 
In conClusion, the results of the present study demonstrate 
the presence of specific receptors for VIP in the proximal tubule 
and suggest that VIP inhibits the Na-H antiporterby a mecha-
nism other than cyClic AMP. Further studies are necessary to 
elucidate the mechanism whereby VIP exerts its tubular effect. 
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